Akt2 Phenotype Annotations - Multigenic Genotypes

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Akt2
thymoma viral proto-oncogene 2
MGI:104874

46 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Akt1^tm1Hem/Akt1⁺ Akt2^tm1Hem/Akt2^tm1Hem Akt3^tm1Hem/Akt3^tm1Hem involves: 129P2/OlaHsd * C57BL/6	decreased body size	J:114675
	decreased body weight	J:114675
Akt1^tm1Hem/Akt1^tm1Hem Akt2^tm1Hem/Akt2^tm1Hem Akt3^tm1Hem/Akt3^tm1Hem involves: 129P2/OlaHsd * C57BL/6	prenatal lethality, complete penetrance	J:114675
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ	decreased circulating leptin level	J:149156
	decreased insulin secretion	J:149156
	decreased pancreatic beta cell number	J:149156
	decreased percent body fat/body weight	J:149156
	decreased white adipose tissue amount	J:149156
	enlarged pancreatic islets	J:149156
	hyperglycemia	J:149156
	impaired glucose tolerance	J:149156
	increased circulating insulin level	J:149156
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg Akt3^tm1Nhy/Akt3^tm1Nhy involves: 129/Sv * C57BL/6 * DBA/1LacJ	hyperglycemia	J:149156
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg Pten^tm1Ppp/Pten⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ	enlarged pancreatic islets	J:149156
	impaired glucose tolerance	J:149156
	increased circulating insulin level	J:149156
Akt1^tm1Nhy/Akt1^tm1Nhy Akt2^tm1Rsg/Akt2^tm1Rsg involves: 129/Sv * C57BL/6 * DBA/1LacJ	abnormal keratinocyte morphology	J:83741
	abnormal lipid homeostasis	J:83741
	decreased birth weight	J:83741
	decreased fetal weight	J:83741
	decreased hair follicle number	J:83741
	delayed bone ossification	J:83741
	muscle hypoplasia	J:83741
	perinatal lethality	J:83741
	respiratory distress	J:83741
	thin epidermis stratum spinosum	J:83741
	thin skin	J:83741
	translucent skin	J:83741
	underdeveloped hair follicles	J:83741
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 involves: 129P2/OlaHsd	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	increased T cell apoptosis	J:135903
	thymus hypoplasia	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(Lck-cre)1Cwi/0 involves: 129P2/OlaHsd	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	increased T cell apoptosis	J:135903
	thymus hypoplasia	J:135903
Akt2^tm1.1Mbb/Akt2⁺ Lep^ob/Lep^ob B6.Cg-Lep^ob Akt2^tm1.1Mbb	decreased body weight	J:155432
	decreased liver triglyceride level	J:155432
	decreased liver weight	J:155432
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Akt3^tm1Mbb/Akt3^tm1Mbb involves: 129P2/OlaHsd	no abnormal phenotype detected	J:135903
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Lep^ob/Lep^ob B6.Cg-Lep^ob Akt2^tm1.1Mbb	abnormal lipid homeostasis	J:155432
	decreased body weight	J:155432
	decreased circulating cholesterol level	J:155432
	decreased liver triglyceride level	J:155432
	decreased liver weight	J:155432
	increased circulating glucose level	J:155432
	increased circulating insulin level	J:155432
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Pten^tm1Hwu/Pten^tm1Hwu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA	abnormal liver morphology	J:218587
	decreased susceptibility to hepatic steatosis	J:218587
	hyperglycemia	J:160759
	impaired glucose tolerance	J:160759
	increased tumor latency	J:218587
	normal liver/biliary system phenotype	J:160759
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul involves: 129 * C57BL/6 * FVB/N	increased mammary adenocarcinoma incidence	J:117336
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(MMTV-PyVT)634Mul/0 involves: 129 * C57BL/6 * FVB/N	increased mammary adenocarcinoma incidence	J:117336
Akt2^tm1.2Mbb/Akt2^tm1.2Mbb Lep^ob/Lep^ob Tg(Alb1-cre)1Khk/0 involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL	abnormal lipid homeostasis	J:155432
	decreased body weight	J:155432
	decreased liver triglyceride level	J:155432
	decreased liver weight	J:155432
	increased circulating glucose level	J:155432
Akt2^tm1Hem/Akt2^tm1Hem Akt3^tm1Hem/Akt3^tm1Hem involves: 129P2/OlaHsd * C57BL/6	abnormal testis morphology	J:114675
	decreased body size	J:114675
	decreased body weight	J:114675
	decreased brain weight	J:114675
	decreased circulating testosterone level	J:114675
	decreased testis weight	J:114675
	hyperglycemia	J:114675
	impaired glucose tolerance	J:114675
	increased circulating insulin level	J:114675
	insulin resistance	J:114675
Akt2^tm1Rsg/Akt2^tm1Rsg Akt3^tm1Nhy/Akt3^tm1Nhy involves: 129/Sv * C57BL/6 * DBA/1LacJ	impaired glucose tolerance	J:149156
Akt2^tm1Rsg/Akt2^tm1Rsg Pten^tm1Ppp/Pten⁺ involves: 129S1/Sv * C57BL/6 * DBA/1LacJ	decreased circulating insulin level	J:149156
	impaired glucose tolerance	J:149156

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24